New Local Coverage Determination (LCD): Genetic Testing for Oncology (Part A/B)

Effective 7/17/2023

With advancement in science and technology comes the ability to incorporate genetic testing for oncology biomarkers into clinical care, with the goal of improved patient outcomes. The scope of this LCD is DNA and RNA genetic testing in the practice of oncology in the Medicare population

Source: https://www.cms.gov/medicare-coverage-database/search-results.aspx?keyword=Genetic+Testing+for+Oncology&keywordType=starts&areaId=all&docType=NCA,CAL,NCD,MEDCAC,TA,MCD,6,3,5,1,F,P&contractOption=all